Earlham College

News from Public Affairs
Contact: Mark Blackmon
Director of Media Relations, 765/983-1256

Earlham News


News Links:


Alumnus on the Cutting Edge of
Biotechnology and Medicine

For Immediate Release:
Jan. 22, 2008

David Stump

David Stump '72 is executive vice president of Human Genome Sciences, Inc. and author/co-author of more than 90 publications.

RICHMOND, Ind. — Internationally recognized as one of the earliest biotechnology researchers and developers, David Stump '72 returns to speak at Earlham College — the place where he first learned to put science in a global and human context.

Stump, a physician and scientist who is executive vice president of Human Genome Sciences Inc., presents "Engaging Genes: At the Intersection of Biotechnology and Medicine" during an Earlham convocation beginning at 1 p.m. Wednesday, Jan. 30, in Carpenter Hall's Goddard Auditorium. The event is free and open to the public.

Stump has been associated with a number of innovative new therapies for patients of heart attack, stroke, immunologic diseases and cancer.

"I have been very fortunate to be closely involved in bringing important new biotechnology drugs to patients," Stump says. "I am especially proud to have played a key role in the studies which demonstrated the lifesaving and life-improving potential of clot dissolving therapy for patients suffering from heart attack or stroke.

"Today my research and development team is investigating a novel new genomic treatment for patients with systemic lupus erythematosis, a disease affecting predominantly young women and without an effective new therapy in the last 40 years."

Human Genome Sciences also is in the late stages of work on ABthrax, a new antibody drug effective against anthrax infection, which is planned to be made available to governments as a defense against bioterrorism. It was announced in December that clinical trials showed that ABthrax improved survival rates up to 64 percent in monkeys infected with anthrax.

"ABthrax is the result of cutting edge research but a drug which I hope will never be used," he says.

During the convocation, Stump also will discuss the impact Earlham has had on his career in gene identification and manipulation in medical and scientific advances achieved through biotechnology.

"I credit my Earlham experience for much of the satisfaction I have enjoyed during my professional career," Stump says. "It was there that I gained the fundamental skills to learn science as well as being challenged to always put science in a global and human context. Earlham inspired me to see the potential for change as energizing and worthy of exploration."

— EC —

Contact:
Mark Blackmon, director of media relations
765/983-1256 — E-Mail Mark

Return to Top

Earlham Home · Public Affairs · Site Index

Earlham College · 801 National Road West · Richmond, Indiana 47374-4095
Send corrections or comments to Web Editor .
Copyright Information

This page last updated: January 22, 2008